D. E. Shaw & Co. Inc. Has $16.51 Million Stake in Henry Schein, Inc. (NASDAQ:HSIC)

D. E. Shaw & Co. Inc. raised its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 45.9% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 238,626 shares of the company's stock after buying an additional 75,118 shares during the period. D. E. Shaw & Co. Inc. owned 0.19% of Henry Schein worth $16,513,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HSIC. Palestra Capital Management LLC purchased a new stake in shares of Henry Schein in the fourth quarter worth about $182,988,000. Lyrical Asset Management LP bought a new stake in shares of Henry Schein in the 4th quarter valued at about $126,655,000. Norges Bank bought a new position in shares of Henry Schein in the fourth quarter worth approximately $103,301,000. National Bank of Canada FI grew its stake in shares of Henry Schein by 102.4% in the fourth quarter. National Bank of Canada FI now owns 1,084,511 shares of the company's stock worth $75,048,000 after purchasing an additional 548,561 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new position in Henry Schein in the 4th quarter worth $34,720,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at $4,460,251.20. The trade was a 6.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the firm's stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now directly owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. This represents a 9.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.08% of the company's stock.

Henry Schein Trading Up 2.7%

NASDAQ HSIC opened at $70.47 on Tuesday. The stock has a market capitalization of $8.58 billion, a PE ratio of 29.00, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. The firm has a 50 day moving average of $67.57 and a two-hundred day moving average of $71.46. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. During the same quarter in the previous year, the business earned $1.10 earnings per share. The firm's revenue for the quarter was down .1% on a year-over-year basis. As a group, research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the stock. Piper Sandler dropped their price target on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 30th. StockNews.com downgraded shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Wells Fargo & Company lowered their target price on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. UBS Group reduced their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Finally, Jefferies Financial Group increased their price target on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Henry Schein has an average rating of "Moderate Buy" and an average price target of $79.30.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.